Topic: cell and gene therapy companies

Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years   Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”. ...